Alhemo Virtual Q+A Virtual Event 4/17/2025
April 17 @ 6:00 pm - 8:00 pm
The HANY team is excited to invite you to join us on April 17th, 2025 for a virtual educational presentation!
This event will be a Virtual Q+A with Novo Nordisk Representative Martha Boria Negron, regarding Alhemo. Alhemo is the first ever subcutaneous pen approved for treatment in those affected by Hemophilia A or B WITH inhibitors.
We urge you to participate in this unique opportunity to bring your questions directly to Martha!
This program is for any patient, caregiver, or family affected by Hemophilia A or B WITH inhibitors.
